“The existing circumstance has exposed some structural weaknesses from the EU’s medicines supply chain and a large dependence on non-EU countries for active pharmaceutical ingredients,” Kyriakides explained. She recommended that offer chain problems be resolved in an EU pharmaceutical technique expected for being launched by the tip in the 12… Read More